Montpellier, France · Founded 2013 · Privately Held (backing)
Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. Sim&Cure is based in Montpellier, France and was founded in 2013. Its last reported valuation was $48.7 million in Nov 2025. It has raised $21.1 million.
Last reported valuation
$48.7M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
—
Cap table — not yet on record
Sim&Cure's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sim&Cure with a free account
·The complete investor list: 13 names
·Watch Sim&Cure: the Monday email on marks, rounds and moves
